MICHAEL FUERST: Open Payments
NPI 1609866037 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 33 payments from 9 companies in 2025. Trend: 2023 $349 · 2024 $283 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| HEARTFLOW, INC. | 7 | $255 |
| Novartis Pharmaceuticals Corporation | 11 | $197 |
| Amgen Inc. | 6 | $106 |
| CVRx, Inc. | 1 | $41 |
| PFIZER INC. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $32 |
| Actelion Pharmaceuticals US, Inc. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: FFRct, LEQVIO, REPATHA, Barostim Neo System, ELIQUIS, CAMZYOS, LifeVest, OPSUMIT.
Industry payments across TN — which companies pay providers there.
